http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112043713-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P33-02
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-645
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112043713-B
titleOfInvention Application of betulinic acid derivative in preparing medicine for treating nerve injury diseases
abstract The invention belongs to the field of medicines, and discloses an application of betulinic acid derivatives or pharmaceutically acceptable salts thereof in preparing medicines for treating nerve injury diseases. The invention successfully carries out structural modification on the betulinic acid by utilizing a microbial transformation technology to obtain a plurality of novel compounds, and in-vitro nerve cell injury protection tests prove that the compounds have better nerve cell protection activity, can be used as active ingredients of medicaments for treating neurodegenerative diseases, traumatic brain injury and stroke, and have wide application.
priorityDate 2020-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103342729-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004037180-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454091746
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451679761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520108
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496247
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433321858
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228520
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16723172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18373917
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44263804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64971
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916

Total number of triples: 52.